Upgrade to SI Premium - Free Trial

Nordson Corporation Reports Third Quarter Fiscal 2024 Results and Updates Annual Guidance

August 21, 2024 4:30 PM

Third Quarter Highlights:

Updated Full-Year Guidance:

WESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal third quarter ended July 31, 2024. Sales were $662 million, compared to the prior year’s third quarter sales of $649 million. The third quarter 2024 sales included a favorable acquisition impact of 4%, partially offset by an organic sales decrease of 1% and unfavorable currency translation of 1%. The organic sales decrease was driven by lower demand in electronics and medical product lines, partially offset by growth in packaging, nonwovens, and optical sensors product lines.

Net income was $117 million, or $2.04 of earnings per diluted share, compared to prior year’s third quarter net income of $128 million, or $2.22 of earnings per diluted share. Adjusted net income was $138 million, a decrease from the prior year adjusted net income of $147 million. Third quarter 2024 adjusted earnings per diluted share were $2.41, a 6% decrease from the prior year adjusted earnings per diluted share of $2.55. The decrease reflects increased interest expense from prior year acquisitions and slightly lower overall operating margins.

EBITDA in the third quarter was $208 million, or 31% of sales, compared to prior year EBITDA of $208 million, or 32% of sales. EBITDA was flat as improved gross margins were offset by higher selling and administrative expenses, including the first-year effect of the ARAG acquisition.

Commenting on the Company’s fiscal 2024 third quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “We delivered third quarter revenue in line with our expectations, driven by strong organic growth in our industrial product lines. Our Advanced Technology Solutions segment sequentially grew compared to second quarter, as order entry steadily improves in electronics end markets. Across the company, the teams executed another solid operating performance delivering strong gross margins and 31% EBITDA margin. Overall, I am pleased with our focus on the customer while managing profitability well against headwinds in select businesses.”

Third Quarter Segment Results

Industrial Precision Solutions sales of $371 million increased 10% from the prior year, inclusive of a favorable acquisition impact of 7%, an organic sales increase of 4% and unfavorable currency translation of 1%. The organic sales increase was driven primarily by packaging and nonwovens product lines. Operating profit was $118 million, an increase of $3 million from the prior year. EBITDA in the quarter was $135 million, or 36% of sales, a 10% increase from the prior year third quarter EBITDA of $122 million, or 36% of sales. The year-over-year increase was driven by the ARAG acquisition, and higher organic sales and gross profit.

Medical and Fluid Solutions sales of $167 million decreased 2% compared to the prior year third quarter. The decrease was driven by lower demand in interventional solutions and fluid components product lines. Operating profit was $48 million, a decrease of $6 million from the prior year. EBITDA in the quarter was $62 million, or 37% of sales, down versus the prior year third quarter EBITDA of $68 million, or 40% of sales.

Advanced Technology Solutions sales of $124 million decreased 11% compared to the prior year third quarter, driven by lower organic sales and unfavorable currency translation of 1%. While sequentially higher, the organic sales decrease compared to prior year was driven by softness in electronics processing and x-ray and test product lines, offset by growth in optical sensors product lines. Operating profit was $23 million, a decrease of $4 million from the prior year. EBITDA in the quarter was $26 million, or 21% of sales, a decrease from the prior year third quarter EBITDA of $33 million, or 24% of sales.

Outlook

The Company is entering the fourth quarter of fiscal 2024 with approximately $650 million in backlog, which continues to normalize and remain concentrated in systems businesses. Based on current visibility and order entry trends, the Company is increasing its full-year revenue guidance range to $2,665 million - $2,705 million, inclusive of revenue from the Atrion acquisition in the fiscal fourth quarter. The Company is tightening full-year adjusted earnings per diluted share to the range of $9.45 - $9.65, unchanged at the midpoint, though now inclusive of the slightly dilutive Atrion impact in the fiscal fourth quarter.

Reflecting on the outlook, Nagarajan continued, “Throughout 2024, we have remained focused on delivering high quality operating performance in a dynamic environment. The diversification of our product portfolio, geographic exposure, mix of recurring revenue, in addition to the NBS Next growth framework and the contributions of our recent acquisitions, are positioning us well to end the year in line with record fiscal 2023 revenue. I remain pleased with our ability to manage profitability during this period, while remaining invested in the long-term objectives of the business.”

Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, August 22, 2024 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or [email protected].

The Company’s definition of adjusted earnings excludes acquisition related amortization for both current and historical periods. It is not possible for the Company to identify the amount or significance of future adjustments associated with acquisition and integration costs, restructuring costs, acquisition-related amortization, certain non-operating or income tax items, or other non-routine costs that the Company adjusts in the presentation of adjusted earnings guidance. These items are dependent on future events that are not reasonably estimable at this time. Accordingly, the Company is unable to reconcile without unreasonable effort the forecasted range of adjusted earnings guidance to a comparable GAAP range.

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions, including the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflict between Russia and Ukraine, acts of terror, natural disasters and pandemics, including the recent coronavirus (COVID-19) pandemic and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, linkedin/Nordson, or www.facebook.com/nordson.

NORDSON CORPORATION

CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(Dollars in thousands except for per-share amounts)

Three Months Ended

Nine Months Ended

July 31, 2024

July 31, 2023

July 31, 2024

July 31, 2023

Sales

$

661,604

$

648,677

$

1,945,439

$

1,909,319

Cost of sales

292,603

288,357

862,134

868,007

Gross profit

369,001

360,320

1,083,305

1,041,312

Gross margin %

55.8

%

55.5

%

55.7

%

54.5

%

Selling & administrative expenses

201,943

189,324

588,196

553,590

Operating profit

167,058

170,996

495,109

487,722

Interest expense - net

(17,776

)

(11,486

)

(56,729

)

(30,904

)

Other income (expense) - net

152

2,542

(971

)

(2,059

)

Income before income taxes

149,434

162,052

437,409

454,759

Income taxes

32,107

34,161

92,293

95,044

Net income

$

117,327

$

127,891

$

345,116

$

359,715

Weighted-average common shares outstanding:

Basic

57,229

56,989

57,171

57,114

Diluted

57,624

57,530

57,620

57,657

Earnings per share:

Basic earnings

$

2.05

$

2.24

$

6.04

$

6.30

Diluted earnings

$

2.04

$

2.22

$

5.99

$

6.24

NORDSON CORPORATION

CONSOLIDATED BALANCE SHEETS (Unaudited)

(Dollars in thousands)

July 31, 2024

October 31, 2023

Cash and cash equivalents

$

165,324

$

115,679

Receivables - net

538,541

590,886

Inventories - net

438,167

454,775

Other current assets

82,106

67,970

Total current assets

1,224,138

1,229,310

Property, plant and equipment - net

401,415

392,846

Goodwill

2,785,773

2,784,201

Other assets

793,044

845,413

$

5,204,370

$

5,251,770

Notes payable and debt due within one year

$

96,288

$

115,662

Accounts payable and accrued liabilities

421,979

466,427

Total current liabilities

518,267

582,089

Long-term debt

1,398,155

1,621,394

Other liabilities

434,191

450,227

Total shareholders' equity

2,853,757

2,598,060

$

5,204,370

$

5,251,770

NORDSON CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

(Dollars in thousands)

Nine Months Ended

July 31, 2024

July 31, 2023

Cash flows from operating activities:

Net income

$

345,116

$

359,715

Depreciation and amortization

99,646

80,637

Other non-cash items

15,435

18,523

Changes in operating assets and liabilities and other

(385

)

19,197

Net cash provided by operating activities

459,812

478,072

Cash flows from investing activities:

Additions to property, plant and equipment

(43,786

)

(24,244

)

Acquisition of businesses, net of cash acquired

(377,843

)

Other - net

8,896

91

Net cash used in investing activities

(34,890

)

(401,996

)

Cash flows from financing activities:

Issuance (repayment) of long-term debt

(244,355

)

73,956

Repayment of finance lease obligations

(4,505

)

(4,769

)

Dividends paid

(116,789

)

(111,547

)

Issuance of common shares

29,142

18,449

Purchase of treasury shares

(34,105

)

(78,163

)

Net cash provided used in financing activities

(370,612

)

(102,074

)

Effect of exchange rate change on cash:

(4,665

)

5,679

Net change in cash and cash equivalents

49,645

(20,319

)

Cash and cash equivalents:

Beginning of period

115,679

163,457

End of period

$

165,324

$

143,138

NORDSON CORPORATION

SALES BY GEOGRAPHIC SEGMENT (Unaudited)

(Dollars in thousands)

Three Months Ended

Sales Variance

July 31, 2024

July 31, 2023

Organic

Acquisitions

Currency

Total

SALES BY SEGMENT

Industrial Precision Solutions

$

370,561

$

338,257

3.6

%

7.4

%

(1.4

)%

9.6

%

Medical and Fluid Solutions

166,737

170,871

(2.0

)%

%

(0.4

)%

(2.4

)%

Advanced Technology Solutions

124,306

139,549

(10.2

)%

%

(0.7

)%

(10.9

)%

Total sales

$

661,604

$

648,677

(0.9

)%

3.8

%

(0.9

)%

2.0

%

SALES BY GEOGRAPHIC REGION

Americas

$

287,016

$

290,515

(3.4

)%

2.4

%

(0.2

)%

(1.2

)%

Europe

179,370

167,536

(2.0

)%

9.8

%

(0.7

)%

7.1

%

Asia Pacific

195,218

190,626

4.1

%

0.8

%

(2.5

)%

2.4

%

Total sales

$

661,604

$

648,677

(0.9

)%

3.8

%

(0.9

)%

2.0

%

Nine Months Ended

Sales Variance

July 31, 2024

July 31, 2023

Organic

Acquisitions

Currency

Total

SALES BY SEGMENT

Industrial Precision Solutions

$

1,092,099

$

985,610

2.5

%

8.8

%

(0.5

)%

10.8

%

Medical and Fluid Solutions

495,229

491,683

0.9

%

%

(0.2

)%

0.7

%

Advanced Technology Solutions

358,111

432,026

(16.6

)%

%

(0.5

)%

(17.1

)%

Total sales

$

1,945,439

$

1,909,319

(2.2

)%

4.5

%

(0.4

)%

1.9

%

SALES BY GEOGRAPHIC REGION

Americas

$

855,456

$

834,125

(0.3

)%

2.7

%

0.2

%

2.6

%

Europe

540,750

498,379

(4.5

)%

12.2

%

0.8

%

8.5

%

Asia Pacific

549,233

576,815

(3.1

)%

0.7

%

(2.4

)%

(4.8

)%

Total sales

$

1,945,439

$

1,909,319

(2.2

)%

4.5

%

(0.4

)%

1.9

%

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited)

(Dollars in thousands)

Three Months Ended

Nine Months Ended

July 31, 2024

July 31, 2023

July 31, 2024

July 31, 2023

Net income

$

117,327

$

127,891

$

345,116

$

359,715

Income taxes

32,107

34,161

92,293

95,044

Interest expense - net

17,776

11,486

56,729

30,904

Other expense - net

(152

)

(2,542

)

971

2,059

Depreciation and amortization

33,382

27,102

99,646

80,637

Inventory step-up amortization (1)

2,944

4,306

Severance and other

2,536

2,049

4,615

5,487

Acquisition-related costs (1)

5,160

7,732

5,757

13,721

EBITDA (non-GAAP) (2)

$

208,136

$

207,879

$

608,071

$

591,873

(1)

Represents fees, severance and non-cash inventory charges associated with acquisitions.

(2)

EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - EBITDA (Unaudited)

(Dollars in thousands)

Three Months Ended

Nine Months Ended

July 31, 2024

July 31, 2023

July 31, 2024

July 31, 2023

SALES BY SEGMENT

Industrial Precision Solutions

$

370,561

$

338,257

$

1,092,099

$

985,610

Medical and Fluid Solutions

166,737

170,871

495,229

491,683

Advanced Technology Solutions

124,306

139,549

358,111

432,026

Total sales

$

661,604

$

648,677

$

1,945,439

$

1,909,319

OPERATING PROFIT

Industrial Precision Solutions

$

118,110

$

115,346

$

344,305

$

329,439

Medical and Fluid Solutions

48,374

54,019

143,467

141,326

Advanced Technology Solutions

22,945

27,083

60,767

70,136

Corporate

(22,371

)

(25,452

)

(53,430

)

(53,179

)

Total operating profit

$

167,058

$

170,996

$

495,109

$

487,722

OPERATING PROFIT ADJUSTMENTS (1)

Industrial Precision Solutions

$

2,536

$

$

6,077

$

Medical and Fluid Solutions

1,479

Advanced Technology Solutions

2,049

2,078

14,303

Corporate

5,160

7,732

5,161

7,732

Total adjustments

$

7,696

$

9,781

$

13,316

$

23,514

DEPRECIATION & AMORTIZATION

Industrial Precision Solutions

$

14,521

$

7,036

$

42,821

$

21,166

Medical and Fluid Solutions

13,553

14,133

40,822

41,441

Advanced Technology Solutions

3,368

3,834

10,093

11,656

Corporate

1,940

2,099

5,910

6,374

Total depreciation & amortization

$

33,382

$

27,102

$

99,646

$

80,637

EBITDA (NON-GAAP) (2)

Industrial Precision Solutions

$

135,167

36%

$

122,382

36%

$

393,203

36%

$

350,605

36%

Medical and Fluid Solutions

61,927

37%

68,152

40%

184,289

37%

184,246

37%

Advanced Technology Solutions

26,313

21%

32,966

24%

72,938

20%

96,095

22%

Corporate

(15,271

)

(15,621

)

(42,359

)

(39,073

)

Total EBITDA

$

208,136

31%

$

207,879

32%

$

608,071

31%

$

591,873

31%

(1)

Represents severance as well as fees and non-cash inventory charges associated with acquisitions.

(2)

EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE

(Unaudited)

(Dollars in thousands)

Three Months Ended

Nine Months Ended

July 31, 2024

July 31, 2023

July 31, 2024

July 31, 2023

GAAP AS REPORTED

Operating profit

$

167,058

$

170,996

$

495,109

$

487,722

Other / interest expense - net

(17,624

)

(8,944

)

(57,700

)

(32,963

)

Net income

117,327

127,891

345,116

359,715

Diluted earnings per share

$

2.04

$

2.22

$

5.99

$

6.24

Shares outstanding - diluted

57,624

57,530

57,620

57,657

OPERATING PROFIT ADJUSTMENTS

Inventory step-up amortization

$

$

$

2,944

$

4,306

Acquisition-related costs

5,160

7,732

5,757

13,721

Severance and other

2,536

2,049

4,615

5,487

ACQUISITION AMORTIZATION OF INTANGIBLES

$

19,202

$

13,922

57,412

41,839

Total adjustments

$

26,898

$

23,703

$

70,728

$

65,353

Adjustments net of tax

$

21,134

$

18,706

$

55,804

$

51,694

EPS effect of adjustments and other discrete tax items

$

0.37

$

0.33

$

0.97

$

0.90

NON-GAAP MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

Adjusted Net income (1)

$

138,461

$

146,597

$

400,920

$

411,409

Adjusted Diluted earnings per share (2)

$

2.41

$

2.55

$

6.96

$

7.14

(1)

Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items.

(2)

Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.

Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.

Lara Mahoney

Vice President, Investor Relations & Corporate Communications

440.204.9985

[email protected]

Source: Nordson Corporation

Categories

Business Wire Press Releases

Next Articles